EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

被引：1
作者：
Karelkina, E. V. [1 ]
Goncharova, N. S. [1 ]
Simakova, M. A. [1 ]
Moiseeva, O. M. [1 ]
机构：
[1] FGBU Natl Med Res Ctr, St Petersburg, Russia
来源：
KARDIOLOGIYA | 2020年 / 60卷 / 04期
关键词：
PROSTACYCLIN-RECEPTOR AGONIST;
D O I：
10.18087/cardio.2020.4.n1026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：36 / 42
页数：6
相关论文
共 42 条
  • [31] Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives
    Zheng, Wei
    Wang, Zhen
    Jiang, Xiangrui
    Zhao, Qingjie
    Shen, Jingshan
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15153 - 15186
  • [32] Advanced Diagnosis and Therapy for Pulmonary Arterial Hypertension
    Qi, Jing
    Xing, Yan
    Zhao, Xiaoting
    Zhu, Daling
    Zheng, Xiaodong
    NANO LIFE, 2020, 10 (1-2)
  • [33] The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future
    Zhao, Jiuliang
    Wang, Qian
    Deng, Xiaoyue
    Qian, Junyan
    Tian, Zhuang
    Liu, Yongtai
    Li, Mengtao
    Zeng, Xiaofeng
    PHARMACOLOGY & THERAPEUTICS, 2022, 239
  • [34] Selexipag for Chronic Thromboembolic Pulmonary Hypertension in Japanese Patients - A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase II Study -
    Tanabe, Nobuhiro
    Fukuda, Keiichi
    Matsubara, Hiromi
    Nakanishi, Norifumi
    Tahara, Nobuhiro
    Ikeda, Satoshi
    Kishi, Takuya
    Satoh, Toru
    Hirata, Ken-ichi
    Inoue, Teruo
    Kimura, Hiroshi
    Okano, Yoshiaki
    Okazaki, Osamu
    Sata, Masataka
    Tsujino, Ichizo
    Ueno, Shuichi
    Yamada, Norikazu
    Yao, Atsushi
    Kuriyama, Takayuki
    CIRCULATION JOURNAL, 2020, 84 (10) : 1866 - 1874
  • [35] Molecular mechanisms involved in pulmonary arterial hypertension development
    Manojlovic, Dragan
    Drenjancevic, Ines
    PERIODICUM BIOLOGORUM, 2011, 113 (03) : 327 - 333
  • [36] Novel investigational therapies for treating pulmonary arterial hypertension
    Sardana, Mayank
    Moll, Matthew
    Farber, Harrison W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (12) : 1571 - 1596
  • [37] Current and Future Therapeutic Targets for Pulmonary Arterial Hypertension
    Fraidenburg, Dustin
    Yuan, Jason
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2013, 14 (02) : 134 - 143
  • [38] Comparing the efficacy and safety of low, medium, and high dosages of selexipag for treating pulmonary hypertension: A systematic review and meta-analysis
    Wang, Shang
    Yan, Yi
    Zhang, Jian
    Yuan, Ping
    Luo, Ci-Jun
    Qiu, Hong-Ling
    Li, Hui-Ting
    Xu, Jian
    Wang, Lan
    Li, Tian-Lan
    Jiang, Rong
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2024, 7 (01) : 56 - 70
  • [39] Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension
    Morrell, Nicholas W.
    Archer, Stephen L.
    DeFelice, Albert
    Evans, Steven
    Fiszman, Monica
    Martin, Thomas
    Saulnier, Muriel
    Rabinovitch, Marlene
    Schermuly, Ralph
    Stewart, Duncan
    Truebel, Hubert
    Walker, Gennyne
    Stenmark, Kurt R.
    PULMONARY CIRCULATION, 2013, 3 (01) : 226 - 244
  • [40] Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
    Jin, Qi
    Chen, Dandan
    Zhang, Xiaochun
    Zhang, Feng
    Zhong, Dongxiang
    Lin, Dawei
    Guan, Lihua
    Pan, Wenzhi
    Zhou, Daxin
    Ge, Junbo
    PHARMACEUTICS, 2023, 15 (06)
12345